Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$3.89M
101.50K shares
REED ELIZABETH E plans to sell 101.50K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $3.89M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Stock Option Exercise Cash | 20K | — |
| Total | 20K | ||
Completed
Units to sell
6.79K
Market value
$283.8K
Units to sell
37.50K
Market value
$1.54M
Units to sell
7.21K
Market value
$302.5K
Units to sell
10K
Market value
$300.0K
Units to sell
10K
Market value
$280.9K
Units to sell
10K
Market value
$278.3K
Planned — Approximate Date
Units to sell
20K
Market value
$900.0K
Units
101.50K
Value
$3.89M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 6.79K | $283.8K | — | Completed |
4/14/2026 | 37.50K | $1.54M | — | Completed |
4/14/2026 | 7.21K | $302.5K | — | Completed |
4/1/2026 | 10K | $300.0K | — | Completed |
3/16/2026 | 10K | $280.9K | — | Completed |
2/17/2026 | 10K | $278.3K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 20K | $900.0K | NASDAQ | Planned |
| Total | 101.50K | $3.89M | ||